Treatment of Sezary Syndrome with Combination Romidepsin and Tofacitinib: a Case Report

Suhl, S., Lapolla, B., Kaminsky, A., & Geskin, L. J. (2025). Treatment of Sezary syndrome with combination romidepsin and tofacitinib: A case report. JAAD Case Reports, 55, 69–72. https://doi.org/10.1016/j.jdcr.2024.11.007
Authors:
Sara Suhl
Brigit A. Lapolla
Alexander J. Kaminsky
Larisa J. Geskin
Affiliated Authors:
Sara Suhl
Brigit A. Lapolla
Alexander J. Kaminsky
Larisa J. Geskin
Columbia Affiliation:
Subjects:
Classification and Treatment of Cutaneous Lymphomas (OpenAlex Topic)
Immunotoxin Therapy for Cancer Treatment (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Author Keywords:
case report
ctcl
cutaneous t-cell lymphoma
hdac
histone deacetylase inhibitor
jak
janus kinase inhibitor
romidepsin
sézary syndrome
tofacitinib
elink
Publication Type:
Article
Unique ID:
10.1016/j.jdcr.2024.11.007
PMID:
39802947
DOI:
10.1016/j.jdcr.2024.11.007
Journal:
JAAD Case Reports
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: